Non-invasive monitoring of liver disease regression in patients with advanced chronic liver disease after sustained virologic response to INF-free therapies

被引：0
|
作者：
Semmler, Georg [1 ,2 ]
Binter, Teresa [1 ]
Kozbial, Karin [1 ]
Schwabl, Philipp [1 ,2 ]
Chromy, David [1 ,2 ]
Bauer, David J. M. [1 ,2 ]
Simbrunner, Benedikt [1 ,2 ]
Scheiner, Bernhard [1 ,2 ]
Bucsics, Theresa [1 ,2 ]
Staettermayer, Albert [1 ,2 ]
Pinter, Matthias [1 ,2 ]
Munda, Petra [1 ]
Trauner, Michael [1 ]
Ferenci, Peter [1 ]
Reiberger, Thomas [1 ,2 ]
Mandorfer, Mattias [1 ,2 ]
机构：
[1] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
[2] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
AS152
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [21] Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease
    Backus, Lisa I.
    Belperio, Pamela S.
    Shahoumian, Troy A.
    Mole, Larry A.
    HEPATOLOGY, 2018, 68 (03) : 827 - 838
  • [22] Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII
    Song, Byeong Geun
    Goh, Myung Ji
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    Sinn, Dong Hyun
    LIVER INTERNATIONAL, 2023, 43 (09) : 1966 - 1974
  • [23] RISK STRATIFICATION AND NON-INVASIVE MONITORING OF PATIENTS WITH PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE
    Mansour, D.
    Gemell, L.
    Byrne, C.
    Masson, S.
    Bannon, M.
    Mountford, C.
    Leyland, H.
    Thompson, N.
    GUT, 2017, 66 : A176 - A176
  • [24] From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
    Diaconu, Catalina
    Radu, Florentina Ionita
    Jinga, Mariana
    Nuta, Petrut
    Bucurica, Sandica
    Macadon, Bogdan
    Patrasescu, Mihaita
    Popescu, Andrada
    Balaban, Vasile
    Voicu, Laura
    Costache, Daniel O.
    Costache, Raluca S.
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2015, 118 (02) : 5 - 12
  • [25] Non-Invasive versus Invasive Assessment of Portal Hypertension in Chronic Liver Disease
    Gaspar, Rui
    Macedo, Guilherme
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2024, 31 (06) : 377 - 387
  • [26] A NON-INVASIVE SCORING SYSTEM FOR ADVANCED LIVER FIBROSIS IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE
    Sachar, Moniyka
    Park, James
    Pan, Jason J.
    GASTROENTEROLOGY, 2022, 162 (07) : S1237 - S1237
  • [27] Usefulness of Non-invasive Markers for Predicting Significant Fibrosis in Patients with Chronic Liver Disease
    Lee, Han Hyo
    Seo, Yeon Seok
    Um, Soon Ho
    Won, Nam Hee
    Yoo, Hanna
    Jung, Eun Suk
    Kwon, Yong Dae
    Park, Sanghoon
    Keum, Bora
    Kim, Yong Sik
    Yim, Hyung Joon
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Kim, Chang Duck
    Ryu, Ho Sang
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (01) : 67 - 74
  • [28] NON-INVASIVE INVESTIGATION OF LIVER-DISEASE IN HEMOPHILIC PATIENTS
    MILLER, EJ
    LEE, CA
    KARAYIANNIS, P
    HAMILTONDUTOIT, SJ
    DICK, R
    THOMAS, HC
    KERNOFF, PBA
    JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (10) : 1039 - 1043
  • [29] Autotaxin is a non-invasive biomarker for estimating chronic liver disease status
    Joshita, Satoru
    Umemura, Takeji
    Usami, Yoko
    Sugiura, Ayumi
    Yamazaki, Tomoo
    Fujimori, Naoyuki
    Matsumoto, Akihiro
    Igarashi, Koji
    Ota, Masao
    Tanaka, Eiji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 216 - 216
  • [30] Chronic Liver Disease with Obesity: Non-invasive Risk Markers tested
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (03): : 190 - +
12345